Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Revenue

Beijing Tiantan Biological Products had revenue of 1.45B CNY in the quarter ending June 30, 2026, a decrease of -18.91%. This brings the company's total for the last twelve months to 5.65B, down -10.28% year-over-year. In the year 2025, Beijing Tiantan Biological Products had annual revenue of 6.17B with 2.26% growth. That makes Beijing Tiantan Biological Products the 8,384th largest company in the world by revenue and 1,283rd in China.

• Revenue (ttm): 5.65B
• Revenue Growth: -10.28%
• P/S Ratio: 4.24
• Revenue / Employee: 1.09M
• Employees: 5,205
• Market Cap: 23.95B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 6.15B 100.0%
• Overseas 1.62M 0.0%

Fiscal year ended Dec 31, 2025 See the full SHA:600161 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.17B	136.17M	2.26%
Dec 31, 2024	6.03B	851.42M	16.44%
Dec 31, 2023	5.18B	919.14M	21.57%
Dec 31, 2022	4.26B	149.15M	3.63%
Dec 31, 2021	4.11B	666.56M	19.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error